Description

Composition

Catalog mixture: VC-CJC (without DAC) + VC-IPA
Composition: CJC-1295 without DAC and Ipamorelin

Scientific Overview

This defined two-component research mixture contains CJC-1295 without drug affinity complex (DAC), a modified GHRH analogue, and ipamorelin, a growth hormone secretagogue receptor agonist.

Research Applications

Suitable for analytical mixture characterization, peptide stability studies, GHRH-receptor and GHSR binding experiments, and controlled comparative signaling assays.

Material Information

Two-component mixture containing 5 mg CJC-1295 without DAC and 5 mg ipamorelin. Batch-specific analytical information, where available, is documented in the corresponding Certificate of Analysis.

Use Restrictions

For laboratory research and analytical use only. Not for human or veterinary use. Not intended for dosing, injection, ingestion, inhalation, topical application, or clinical administration.

Product Representation: Product imagery is standardized for catalog consistency. Physical container attributes, including cap and crimp color, may vary by batch.